This does not automatically make supplements unsafe, but it does mean that consumers bear more responsibility for evaluating product quality and claims
If approved, we believe pemvidutide could offer an important option for obesity patients, including those with risk factors for cardiovascular disease. However, tolerability issues remain, as the trial led to one participant experiencing vomiting, and 4.1% of the patients in the drug cohort discontinuing treatment in the first 16 weeks, when compared to 2.1% in the placebo group
Endocrinology, 152 , 33623372
Round up to the nearest 1,000mg capsule to maximize buffering
Medical Perspective What are some other supplements that could help fill nutrient gaps in folks taking GLP-1s
While the thought of self-administering injections may seem daunting, our clients typically find they quickly become routine